Exact Mass: 283.0051

Exact Mass Matches: 283.0051

Found 32 metabolites which its exact mass value is equals to given mass value 283.0051, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Risedronate

[1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonic acid

C7H11NO7P2 (283.0011)


Risedronate is only found in individuals that have used or taken this drug. It is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Pagets disease of bone.The action of risedronate on bone tissue is based partly on its affinity for hydroxyapatite, which is part of the mineral matrix of bone. Risedronate also targets farnesyl pyrophosphate (FPP) synthase. Nitrogen-containing bisphosphonates (such as pamidronate, alendronate, risedronate, ibandronate and zoledronate) appear to act as analogues of isoprenoid diphosphate lipids, thereby inhibiting FPP synthase, an enzyme in the mevalonate pathway. Inhibition of this enzyme in osteoclasts prevents the biosynthesis of isoprenoid lipids (FPP and GGPP) that are essential for the post-translational farnesylation and geranylgeranylation of small GTPase signalling proteins. This activity inhibits osteoclast activity and reduces bone resorption and turnover. In postmenopausal women, it reduces the elevated rate of bone turnover, leading to, on average, a net gain in bone mass. M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

   

5-(3-Hydroxybenzoyl)-2-thiophenesulfonamide

5-(3-Hydroxybenzoyl)-2-thiophenesulphonamide

C11H9NO4S2 (282.9973)


   

2-nitro-3-[(phenylsulfonyl)methyl]thiophene

2-nitro-3-[(phenylsulfonyl)methyl]thiophene

C11H9NO4S2 (282.9973)


   

2,6-Dimethyl-3-(2-propenyl)benzothiazolium bromide

2,6-Dimethyl-3-(2-propenyl)benzothiazolium bromide

C12H14BrNS (283.003)


   

3-AMINO-4(PHENYLSULFONYL)THIOPHENE-2-CARBOXYLIC ACID

3-AMINO-4(PHENYLSULFONYL)THIOPHENE-2-CARBOXYLIC ACID

C11H9NO4S2 (282.9973)


   

METHYL 2-[[5-(TRIFLUOROMETHYL)-2-PYRIDYL]SULFONYL]ACETATE

METHYL 2-[[5-(TRIFLUOROMETHYL)-2-PYRIDYL]SULFONYL]ACETATE

C9H8F3NO4S (283.0126)


   

4-(5-Aminosulfonylthiophen-2-yl)benzoic acid

4-(5-Aminosulfonylthiophen-2-yl)benzoic acid

C11H9NO4S2 (282.9973)


   

2-BROMO-6-METHYL-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXYLIC ACID ETHYL ESTER

2-BROMO-6-METHYL-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXYLIC ACID ETHYL ESTER

C10H10BrN3O2 (282.9956)


   

Butanedioic acid, (2-benzothiazolylthio)-

Butanedioic acid, (2-benzothiazolylthio)-

C11H9NO4S2 (282.9973)


   

4-ACETYLAMINO-NAPHTHALENE-1-SULFONYL CHLORIDE

4-ACETYLAMINO-NAPHTHALENE-1-SULFONYL CHLORIDE

C12H10ClNO3S (283.007)


   

4-Hydroxy-5-methoxy-N-phenylnicotinamide

4-Hydroxy-5-methoxy-N-phenylnicotinamide

C11H14BrNOSi (283.0028)


   

6-Bromo-2-phenylquinoline

6-Bromo-2-phenylquinoline

C15H10BrN (282.9997)


   

4-Bromo-2-phenylquinoline

4-Bromo-2-phenylquinoline

C15H10BrN (282.9997)


   

ETHYL 2-(4-CHLOROPHENYL)-4-HYDROXYTHIAZOLE-5-CARBOXYLATE

Ethyl 2-(4-chlorophenyl)-4-hydroxy-1,3-thiazole-5-carboxylate

C12H10ClNO3S (283.007)


   

5-OXO-6-TRIFLUOROMETHANESULFONYLOXY-1,2,3,5-TETRAHYDROINDOLIZINE

5-OXO-6-TRIFLUOROMETHANESULFONYLOXY-1,2,3,5-TETRAHYDROINDOLIZINE

C9H8F3NO4S (283.0126)


   

7-Bromo-2-phenylquinoline

7-Bromo-2-phenylquinoline

C15H10BrN (282.9997)


   

8-Bromo-2-phenylquinoline

8-Bromo-2-phenylquinoline

C15H10BrN (282.9997)


   

2-(4-Bromophenyl)quinoline

2-(4-Bromophenyl)quinoline

C15H10BrN (282.9997)


   

1-(2-Bromophenyl)isoquinoline

1-(2-Bromophenyl)isoquinoline

C15H10BrN (282.9997)


   

(([3-(TRIFLUOROMETHYL)PHENYL]SULFONYL)AMINO)ACETIC ACID

(([3-(TRIFLUOROMETHYL)PHENYL]SULFONYL)AMINO)ACETIC ACID

C9H8F3NO4S (283.0126)


   

2-Methyl-2-propanyl 3-iodo-1-azetidinecarboxylate

2-Methyl-2-propanyl 3-iodo-1-azetidinecarboxylate

C8H14INO2 (283.0069)


   

o-chlorophenyl o-aminobenzenesulphonate

o-chlorophenyl o-aminobenzenesulphonate

C12H10ClNO3S (283.007)


   

4-bromo-2-phenyl-quinoline

4-bromo-2-phenyl-quinoline

C15H10BrN (282.9997)


   

3-ACETYL-N-(4-CHLOROBENZENESULFONYL)PYRROLE

3-ACETYL-N-(4-CHLOROBENZENESULFONYL)PYRROLE

C12H10ClNO3S (283.007)


   

1-(6-(trichlorosilyl)hexyl)1h-pyrrole

1-(6-(trichlorosilyl)hexyl)1h-pyrrole

C10H16Cl3NSi (283.0118)


   

3-BENZYLOXY-PYRIDINE-2-SULFONYL CHLORIDE

3-BENZYLOXY-PYRIDINE-2-SULFONYL CHLORIDE

C12H10ClNO3S (283.007)


   

2,4-DIMETHYL-3-BENZYL-THIAZOLIUM BROMIDE

2,4-DIMETHYL-3-BENZYL-THIAZOLIUM BROMIDE

C12H14BrNS (283.003)


   

4-(Methylsulfonamido)-2-(trifluoromethyl)benzoic Acid

4-(Methylsulfonamido)-2-(trifluoromethyl)benzoic Acid

C9H8F3NO4S (283.0126)


   

5-amino-4-chloro-2-(2-oxidomuconoyl)pyridazin-3(2H)-one(2-)

5-amino-4-chloro-2-(2-oxidomuconoyl)pyridazin-3(2H)-one(2-)

C10H6ClN3O5-2 (282.9996)


   

cis-[PtCl(NH3)2(H2O)]+

cis-[PtCl(NH3)2(H2O)]+

ClH9N2OPt+ (283.0051)


   

Risedronic acid

Risedronic acid

C7H11NO7P2 (283.0011)


M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

   

NS3861

NS3861

C12H14BrNS (283.003)


NS3861 is an agonist of nicotinic acetylcholine receptors (nAChRs) and binds with high affinity to heteromeric α3β4 nAChR. The binding Ki values of 0.62, 25, 7.8, 55 nM for α3β4, α3β2, α4β4, α4β2, respectively[1].